but more rationally and financially sound consideration should place this stock around $300- $500 mill after phase one into phase three based on past peer pricing across the board references acw relative value presentations and just recently imu presentation of similar bio pricing of companies at various stages of fda progress and deals not my analysis just facts of price deals so blue sky here for those that believe that rec will progess fda trials/ examinations easily all the pre clinical trials and tests suggest so and thats before the wild card of covid efficacy as a treatment option in added on also now uti infections therapy, likely solution to gonorrhea resistance issues to penicillin, and topical treatment of burns more efficaciously
what a multiple playground dyi - look up my references here - not pumping and dumping - just pointing you guys to the horizon im more excited now sure every month its just expanding in possibilities
RCE Price at posting:
68.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)